Epiodyne is developing breakthrough opioid medicines to manage pain and treat opioid use disorder (OUD) with minimal potential for addiction and safety risks.
  • 2016 - Founded
  • 2018 - Partnered, Series A

Partners

Great companies are being built by amazing teams.